^
+ Follow NEBIVOLOL Tag
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 942443
                    [Title] => Menarini provides Pinoys with innovative, affordable drugs for cardiovascular diseases
                    [Summary] => 

Italy’s leading research-based pharmaceutical company Menarini is committed to providing Filipino patients with innovative and affordable treatment options for cardiovascular diseases, the leading cause of death in the Philippines.

[DatePublished] => 2013-05-16 00:00:00 [ColumnID] => 0 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) [1] => Array ( [ArticleID] => 838599 [Title] => Invida launches beta blocker with dual action for hypertension, heart failure [Summary] =>

Invida Philippines, the local subsidiary of leading Italian research-based pharmaceutical group Menarini, has launched Nebivolol, a highly cardioselective beta blocker that effectively treats hypertension and congestive heart failure (CHF).

[DatePublished] => 2012-08-16 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
NEBIVOLOL
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 942443
                    [Title] => Menarini provides Pinoys with innovative, affordable drugs for cardiovascular diseases
                    [Summary] => 

Italy’s leading research-based pharmaceutical company Menarini is committed to providing Filipino patients with innovative and affordable treatment options for cardiovascular diseases, the leading cause of death in the Philippines.

[DatePublished] => 2013-05-16 00:00:00 [ColumnID] => 0 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) [1] => Array ( [ArticleID] => 838599 [Title] => Invida launches beta blocker with dual action for hypertension, heart failure [Summary] =>

Invida Philippines, the local subsidiary of leading Italian research-based pharmaceutical group Menarini, has launched Nebivolol, a highly cardioselective beta blocker that effectively treats hypertension and congestive heart failure (CHF).

[DatePublished] => 2012-08-16 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
abtest
Are you sure you want to log out?
X
Login

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

Get Updated:

Signup for the News Round now

FORGOT PASSWORD?
SIGN IN
or sign in with